Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.63647298 |
2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.67001450 |
3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.30367071 |
4 | regulation of gamma-delta T cell activation (GO:0046643) | 6.05977359 |
5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.01634357 |
6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.01634357 |
7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.62128612 |
8 | positive thymic T cell selection (GO:0045059) | 5.51930187 |
9 | negative T cell selection (GO:0043383) | 5.49084670 |
10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.44256827 |
11 | negative thymic T cell selection (GO:0045060) | 5.37649479 |
12 | response to interleukin-15 (GO:0070672) | 5.03873921 |
13 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.91693673 |
14 | cellular response to interleukin-15 (GO:0071350) | 4.82639474 |
15 | thymic T cell selection (GO:0045061) | 4.79419726 |
16 | positive T cell selection (GO:0043368) | 4.77434557 |
17 | regulation of regulatory T cell differentiation (GO:0045589) | 4.76123643 |
18 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.73352527 |
19 | negative regulation of cell killing (GO:0031342) | 4.69633649 |
20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.69633649 |
21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.66354607 |
22 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.57879885 |
23 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.54026136 |
24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.47404939 |
25 | interferon-gamma production (GO:0032609) | 4.47064845 |
26 | T cell selection (GO:0045058) | 4.44084207 |
27 | negative regulation of T cell mediated immunity (GO:0002710) | 4.32505769 |
28 | T cell migration (GO:0072678) | 4.21261615 |
29 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.14642190 |
30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.13380866 |
31 | ribosomal small subunit assembly (GO:0000028) | 4.10058627 |
32 | positive regulation by symbiont of host defense response (GO:0052509) | 4.08629565 |
33 | modulation by symbiont of host defense response (GO:0052031) | 4.08629565 |
34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.08629565 |
35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.08629565 |
36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.08629565 |
37 | modulation by symbiont of host immune response (GO:0052553) | 4.08629565 |
38 | detection of other organism (GO:0098543) | 4.03555143 |
39 | regulation of B cell differentiation (GO:0045577) | 4.00155718 |
40 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.97707841 |
41 | detection of bacterium (GO:0016045) | 3.94778045 |
42 | tolerance induction (GO:0002507) | 3.93052286 |
43 | B cell receptor signaling pathway (GO:0050853) | 3.89128246 |
44 | mature B cell differentiation involved in immune response (GO:0002313) | 3.88346447 |
45 | T cell receptor signaling pathway (GO:0050852) | 3.87683043 |
46 | response to type I interferon (GO:0034340) | 3.87551973 |
47 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.84483223 |
48 | positive regulation of B cell differentiation (GO:0045579) | 3.81781345 |
49 | regulation of T cell tolerance induction (GO:0002664) | 3.81206425 |
50 | cellular response to type I interferon (GO:0071357) | 3.81086397 |
51 | type I interferon signaling pathway (GO:0060337) | 3.81086397 |
52 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.79223059 |
53 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.76888941 |
54 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.76888941 |
55 | neutrophil activation involved in immune response (GO:0002283) | 3.72739912 |
56 | mature B cell differentiation (GO:0002335) | 3.72449863 |
57 | mast cell activation (GO:0045576) | 3.69912472 |
58 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.69729732 |
59 | T cell homeostasis (GO:0043029) | 3.64881245 |
60 | lymph node development (GO:0048535) | 3.63706817 |
61 | leukocyte aggregation (GO:0070486) | 3.61345105 |
62 | negative regulation of interleukin-12 production (GO:0032695) | 3.60407132 |
63 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.59809225 |
64 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.59809225 |
65 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.57543872 |
66 | definitive hemopoiesis (GO:0060216) | 3.56928334 |
67 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.56561065 |
68 | viral transcription (GO:0019083) | 3.56419958 |
69 | activated T cell proliferation (GO:0050798) | 3.55759855 |
70 | positive regulation of humoral immune response (GO:0002922) | 3.51541767 |
71 | response to interferon-beta (GO:0035456) | 3.51525610 |
72 | lymphocyte costimulation (GO:0031294) | 3.50030794 |
73 | T cell costimulation (GO:0031295) | 3.49796342 |
74 | positive regulation of tolerance induction (GO:0002645) | 3.48506273 |
75 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.47842452 |
76 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.45397104 |
77 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.44167586 |
78 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.43972051 |
79 | positive regulation of interleukin-2 production (GO:0032743) | 3.40990117 |
80 | macrophage activation involved in immune response (GO:0002281) | 3.40856387 |
81 | cellular extravasation (GO:0045123) | 3.39458117 |
82 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.39413408 |
83 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.38967643 |
84 | translational termination (GO:0006415) | 3.37316066 |
85 | positive regulation of isotype switching (GO:0045830) | 3.36717946 |
86 | immunoglobulin mediated immune response (GO:0016064) | 3.35435508 |
87 | T cell differentiation (GO:0030217) | 3.35230900 |
88 | myeloid dendritic cell activation (GO:0001773) | 3.34142216 |
89 | megakaryocyte development (GO:0035855) | 3.33858332 |
90 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.33412492 |
91 | regulation of response to interferon-gamma (GO:0060330) | 3.32348429 |
92 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.31868048 |
93 | detection of external biotic stimulus (GO:0098581) | 3.27225298 |
94 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.25023967 |
95 | NIK/NF-kappaB signaling (GO:0038061) | 3.24731170 |
96 | response to muramyl dipeptide (GO:0032495) | 3.23011033 |
97 | negative regulation of innate immune response (GO:0045824) | 3.22978276 |
98 | positive regulation of B cell mediated immunity (GO:0002714) | 3.22606927 |
99 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.22606927 |
100 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.21850039 |
101 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.19394734 |
102 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17358813 |
103 | neutrophil activation (GO:0042119) | 3.16155359 |
104 | regulation of B cell mediated immunity (GO:0002712) | 3.16009143 |
105 | lymphocyte homeostasis (GO:0002260) | 3.15548807 |
106 | regulation of tolerance induction (GO:0002643) | 3.15330229 |
107 | response to protozoan (GO:0001562) | 3.13458586 |
108 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.12602755 |
109 | cellular response to interferon-beta (GO:0035458) | 3.11942695 |
110 | positive regulation of DNA recombination (GO:0045911) | 3.11673519 |
111 | regulation of cell killing (GO:0031341) | 3.10637056 |
112 | positive regulation of cell killing (GO:0031343) | 3.09982740 |
113 | defense response to protozoan (GO:0042832) | 3.09960421 |
114 | platelet dense granule organization (GO:0060155) | 3.09814935 |
115 | regulation of isotype switching (GO:0045191) | 3.08253117 |
116 | response to peptidoglycan (GO:0032494) | 3.06421322 |
117 | Peyers patch development (GO:0048541) | 3.05684506 |
118 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.05684506 |
119 | leukocyte homeostasis (GO:0001776) | 3.05465925 |
120 | positive regulation of granulocyte differentiation (GO:0030854) | 3.04390095 |
121 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.04277549 |
122 | mast cell activation involved in immune response (GO:0002279) | 3.03843888 |
123 | mast cell degranulation (GO:0043303) | 3.03843888 |
124 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.03283954 |
125 | myeloid cell activation involved in immune response (GO:0002275) | 3.03123795 |
126 | ribosomal small subunit biogenesis (GO:0042274) | 3.02414971 |
127 | myeloid dendritic cell differentiation (GO:0043011) | 3.01164269 |
128 | respiratory burst (GO:0045730) | 2.95899847 |
129 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93216219 |
130 | dendritic cell chemotaxis (GO:0002407) | 2.93211654 |
131 | leukocyte degranulation (GO:0043299) | 2.92843385 |
132 | regulation of T cell mediated immunity (GO:0002709) | 2.90806501 |
133 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.86882165 |
134 | dendritic cell migration (GO:0036336) | 2.86216328 |
135 | response to host immune response (GO:0052572) | 2.85224212 |
136 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85224212 |
137 | germinal center formation (GO:0002467) | 2.84421256 |
138 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.83707142 |
139 | detection of biotic stimulus (GO:0009595) | 2.83434908 |
140 | detection of molecule of bacterial origin (GO:0032490) | 2.82322852 |
141 | granulocyte activation (GO:0036230) | 2.82175671 |
142 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.80910214 |
143 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.80910214 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.60328046 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.53469207 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.23606984 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.64748535 |
5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.71014953 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.64204624 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.60324891 |
8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.49212954 |
9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.29893412 |
10 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.29118655 |
11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.24586199 |
12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.23892120 |
13 | MYC_22102868_ChIP-Seq_BL_Human | 3.07428374 |
14 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.03697041 |
15 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.02930260 |
16 | MYB_26560356_Chip-Seq_TH2_Human | 2.98945343 |
17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.74907826 |
18 | * MAF_26560356_Chip-Seq_TH1_Human | 2.72093851 |
19 | MYB_26560356_Chip-Seq_TH1_Human | 2.62442242 |
20 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44524081 |
21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.39653437 |
22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.37141671 |
23 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.36596022 |
24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.24336420 |
25 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18476779 |
26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.17412461 |
27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.14927719 |
28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11152955 |
29 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07969425 |
30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.04624597 |
31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.02808082 |
32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.99831266 |
33 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97612111 |
34 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95979416 |
35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.89194292 |
36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.85914279 |
37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.83611523 |
38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82741443 |
39 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76316161 |
40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75671046 |
41 | MAF_26560356_Chip-Seq_TH2_Human | 1.74864359 |
42 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.74580635 |
43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73021032 |
44 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70919362 |
45 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.68293392 |
46 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.67472247 |
47 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.55386116 |
48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.51228984 |
49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50182501 |
50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48887591 |
51 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.48670430 |
52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47654245 |
53 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.46460482 |
54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45029783 |
55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39961264 |
56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39372889 |
57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38153785 |
58 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37752699 |
59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.36622040 |
60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33352288 |
61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.32087375 |
62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.28933114 |
63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28099356 |
64 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26866628 |
65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23418594 |
66 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23204278 |
67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20996615 |
68 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.20958401 |
69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20813463 |
70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18692046 |
71 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17491187 |
72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16825969 |
73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15704401 |
74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13786624 |
75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13624615 |
76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11757051 |
77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09748919 |
78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07116432 |
79 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06310217 |
80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05917902 |
81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05716084 |
82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05678089 |
83 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.03514569 |
84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99272076 |
85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99188497 |
86 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.99133500 |
87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98572036 |
88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97930679 |
89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92457217 |
90 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92128731 |
91 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.91387381 |
92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91175534 |
93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87403406 |
94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87334300 |
95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83129740 |
96 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82841253 |
97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82304684 |
98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81430959 |
99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80318893 |
100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80076816 |
101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79668205 |
102 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.79647035 |
103 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.79509198 |
104 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.78977453 |
105 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78847869 |
106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77968808 |
107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.77914775 |
108 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77546038 |
109 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.77448299 |
110 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77283246 |
111 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.76329950 |
112 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.76110841 |
113 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.73984666 |
114 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72159247 |
115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71138812 |
116 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.70535614 |
117 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.68791076 |
118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.67095414 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 4.44440488 |
2 | MP0005671_abnormal_response_to | 4.35891770 |
3 | MP0000685_abnormal_immune_system | 3.86341489 |
4 | MP0001835_abnormal_antigen_presentation | 3.77064438 |
5 | MP0009785_altered_susceptibility_to | 3.31554196 |
6 | MP0001800_abnormal_humoral_immune | 3.25351158 |
7 | MP0003724_increased_susceptibility_to | 2.99666108 |
8 | MP0001790_abnormal_immune_system | 2.93369603 |
9 | MP0005387_immune_system_phenotype | 2.93369603 |
10 | MP0002166_altered_tumor_susceptibility | 2.84224590 |
11 | MP0002420_abnormal_adaptive_immunity | 2.77569843 |
12 | MP0002723_abnormal_immune_serum | 2.76571709 |
13 | MP0002398_abnormal_bone_marrow | 2.73757431 |
14 | MP0001819_abnormal_immune_cell | 2.73125506 |
15 | MP0002396_abnormal_hematopoietic_system | 2.72053106 |
16 | MP0005000_abnormal_immune_tolerance | 2.71586513 |
17 | MP0002452_abnormal_antigen_presenting | 2.70621089 |
18 | MP0005025_abnormal_response_to | 2.53998500 |
19 | MP0004808_abnormal_hematopoietic_stem | 2.40680967 |
20 | MP0000716_abnormal_immune_system | 2.38660677 |
21 | MP0001873_stomach_inflammation | 2.37883265 |
22 | MP0000689_abnormal_spleen_morphology | 2.28076544 |
23 | MP0009333_abnormal_splenocyte_physiolog | 2.25448872 |
24 | MP0002722_abnormal_immune_system | 2.21843151 |
25 | MP0010155_abnormal_intestine_physiology | 2.18348790 |
26 | MP0002405_respiratory_system_inflammati | 2.15549190 |
27 | MP0002006_tumorigenesis | 2.13749585 |
28 | MP0000703_abnormal_thymus_morphology | 2.13555648 |
29 | MP0003866_abnormal_defecation | 2.12465525 |
30 | MP0002148_abnormal_hypersensitivity_rea | 2.10227124 |
31 | MP0005464_abnormal_platelet_physiology | 2.05865878 |
32 | MP0003436_decreased_susceptibility_to | 2.04859686 |
33 | MP0002429_abnormal_blood_cell | 2.02660312 |
34 | MP0006082_CNS_inflammation | 1.98683376 |
35 | MP0002419_abnormal_innate_immunity | 1.89785168 |
36 | MP0004947_skin_inflammation | 1.82471794 |
37 | MP0001879_abnormal_lymphatic_vessel | 1.78450832 |
38 | MP0001853_heart_inflammation | 1.75455461 |
39 | MP0005075_abnormal_melanosome_morpholog | 1.75305027 |
40 | MP0010368_abnormal_lymphatic_system | 1.66815675 |
41 | MP0003300_gastrointestinal_ulcer | 1.64983458 |
42 | MP0005397_hematopoietic_system_phenotyp | 1.61423444 |
43 | MP0001545_abnormal_hematopoietic_system | 1.61423444 |
44 | MP0001845_abnormal_inflammatory_respons | 1.60499469 |
45 | MP0004510_myositis | 1.57942740 |
46 | MP0000465_gastrointestinal_hemorrhage | 1.57458518 |
47 | MP0004147_increased_porphyrin_level | 1.50919764 |
48 | MP0002933_joint_inflammation | 1.49902319 |
49 | MP0005174_abnormal_tail_pigmentation | 1.40455135 |
50 | MP0000490_abnormal_crypts_of | 1.30691215 |
51 | MP0009278_abnormal_bone_marrow | 1.27141281 |
52 | MP0008260_abnormal_autophagy | 1.24378659 |
53 | MP0008469_abnormal_protein_level | 1.21211941 |
54 | MP0006054_spinal_hemorrhage | 1.18672220 |
55 | MP0004130_abnormal_muscle_cell | 1.17796232 |
56 | MP0009379_abnormal_foot_pigmentation | 1.15494972 |
57 | MP0003828_pulmonary_edema | 1.13260939 |
58 | MP0003943_abnormal_hepatobiliary_system | 1.12897447 |
59 | MP0002009_preneoplasia | 1.10158825 |
60 | MP0004883_abnormal_blood_vessel | 1.09971611 |
61 | MP0001851_eye_inflammation | 1.07191747 |
62 | MP0002095_abnormal_skin_pigmentation | 1.07040426 |
63 | MP0003690_abnormal_glial_cell | 1.00007585 |
64 | MP0001533_abnormal_skeleton_physiology | 0.99271862 |
65 | MP0002019_abnormal_tumor_incidence | 0.97426997 |
66 | MP0005310_abnormal_salivary_gland | 0.95147195 |
67 | MP0000858_altered_metastatic_potential | 0.92362259 |
68 | MP0003183_abnormal_peptide_metabolism | 0.92231203 |
69 | MP0002277_abnormal_respiratory_mucosa | 0.91367425 |
70 | MP0003303_peritoneal_inflammation | 0.90573549 |
71 | MP0008995_early_reproductive_senescence | 0.90486958 |
72 | MP0000015_abnormal_ear_pigmentation | 0.88868959 |
73 | MP0003172_abnormal_lysosome_physiology | 0.88532283 |
74 | MP0005166_decreased_susceptibility_to | 0.88406150 |
75 | MP0004381_abnormal_hair_follicle | 0.87642391 |
76 | MP0003448_altered_tumor_morphology | 0.87451313 |
77 | MP0002132_abnormal_respiratory_system | 0.87041108 |
78 | MP0003075_altered_response_to | 0.84954103 |
79 | MP0008058_abnormal_DNA_repair | 0.81285587 |
80 | MP0005164_abnormal_response_to | 0.78678294 |
81 | MP0005390_skeleton_phenotype | 0.77773812 |
82 | MP0005451_abnormal_body_composition | 0.76546091 |
83 | MP0000249_abnormal_blood_vessel | 0.74943736 |
84 | MP0002138_abnormal_hepatobiliary_system | 0.71490052 |
85 | MP0005409_darkened_coat_color | 0.71206370 |
86 | MP0002998_abnormal_bone_remodeling | 0.70601318 |
87 | MP0009763_increased_sensitivity_to | 0.70479324 |
88 | MP0004484_altered_response_of | 0.68486293 |
89 | MP0005058_abnormal_lysosome_morphology | 0.66824675 |
90 | MP0003045_fibrosis | 0.66388393 |
91 | MP0008007_abnormal_cellular_replicative | 0.66036501 |
92 | MP0009764_decreased_sensitivity_to | 0.65733904 |
93 | MP0000604_amyloidosis | 0.64171060 |
94 | MP0001191_abnormal_skin_condition | 0.62522156 |
95 | MP0005167_abnormal_blood-brain_barrier | 0.62231996 |
96 | MP0009765_abnormal_xenobiotic_induced | 0.61440025 |
97 | MP0008057_abnormal_DNA_replication | 0.60880203 |
98 | MP0000343_altered_response_to | 0.60436261 |
99 | MP0008874_decreased_physiological_sensi | 0.60184488 |
100 | MP0003191_abnormal_cellular_cholesterol | 0.59464066 |
101 | MP0002136_abnormal_kidney_physiology | 0.58698683 |
102 | MP0000477_abnormal_intestine_morphology | 0.57766374 |
103 | MP0005023_abnormal_wound_healing | 0.57745717 |
104 | MP0001986_abnormal_taste_sensitivity | 0.57277309 |
105 | MP0003786_premature_aging | 0.53697705 |
106 | MP0009115_abnormal_fat_cell | 0.53579843 |
107 | MP0003077_abnormal_cell_cycle | 0.52852350 |
108 | MP0003279_aneurysm | 0.52518134 |
109 | MP0000767_abnormal_smooth_muscle | 0.52202906 |
110 | MP0003091_abnormal_cell_migration | 0.49893302 |
111 | MP0001663_abnormal_digestive_system | 0.49307981 |
112 | MP0002133_abnormal_respiratory_system | 0.49199855 |
113 | MP0005388_respiratory_system_phenotype | 0.49199855 |
114 | MP0000313_abnormal_cell_death | 0.48704886 |
115 | MP0000372_irregular_coat_pigmentation | 0.48412362 |
116 | MP0003656_abnormal_erythrocyte_physiolo | 0.47799537 |
117 | MP0000609_abnormal_liver_physiology | 0.46756579 |
118 | MP0009697_abnormal_copulation | 0.46007634 |
119 | MP0008004_abnormal_stomach_pH | 0.45760902 |
120 | MP0000598_abnormal_liver_morphology | 0.44442025 |
121 | MP0003795_abnormal_bone_structure | 0.43297371 |
122 | MP0005084_abnormal_gallbladder_morpholo | 0.43125312 |
123 | MP0005334_abnormal_fat_pad | 0.42988137 |
124 | MP0003638_abnormal_response/metabolism_ | 0.42180187 |
125 | MP0002928_abnormal_bile_duct | 0.41979894 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.28961018 |
2 | IgM deficiency (HP:0002850) | 5.21787982 |
3 | T lymphocytopenia (HP:0005403) | 5.12046606 |
4 | Abnormality of T cell number (HP:0011839) | 5.02588430 |
5 | Recurrent bronchitis (HP:0002837) | 4.98574161 |
6 | Myositis (HP:0100614) | 4.70125134 |
7 | Chronic otitis media (HP:0000389) | 4.52544034 |
8 | Abnormality of T cells (HP:0002843) | 4.45416212 |
9 | Panhypogammaglobulinemia (HP:0003139) | 4.42634054 |
10 | IgG deficiency (HP:0004315) | 4.23254319 |
11 | Abnormality of macrophages (HP:0004311) | 4.17834993 |
12 | Agammaglobulinemia (HP:0004432) | 4.10170371 |
13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.08935607 |
14 | Gastrointestinal infarctions (HP:0005244) | 4.03522174 |
15 | Abnormality of the nasal mucosa (HP:0000433) | 3.98249116 |
16 | Thrombocytosis (HP:0001894) | 3.92435418 |
17 | Recurrent viral infections (HP:0004429) | 3.90734615 |
18 | Severe combined immunodeficiency (HP:0004430) | 3.89737067 |
19 | Lymphopenia (HP:0001888) | 3.86698643 |
20 | Spontaneous hematomas (HP:0007420) | 3.84277029 |
21 | B lymphocytopenia (HP:0010976) | 3.83594665 |
22 | Abnormality of B cell number (HP:0010975) | 3.83594665 |
23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.76380946 |
24 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.68695407 |
25 | Abnormality of T cell physiology (HP:0011840) | 3.67879032 |
26 | Thyroiditis (HP:0100646) | 3.60848158 |
27 | Nasal polyposis (HP:0100582) | 3.59528847 |
28 | Recurrent fungal infections (HP:0002841) | 3.52306426 |
29 | Combined immunodeficiency (HP:0005387) | 3.47635091 |
30 | Prolonged bleeding time (HP:0003010) | 3.47333228 |
31 | Stomatitis (HP:0010280) | 3.42690169 |
32 | Inflammation of the large intestine (HP:0002037) | 3.39023288 |
33 | Chronic obstructive pulmonary disease (HP:0006510) | 3.37434135 |
34 | Obstructive lung disease (HP:0006536) | 3.37434135 |
35 | Gastrointestinal inflammation (HP:0004386) | 3.32750656 |
36 | Meningitis (HP:0001287) | 3.29322343 |
37 | Colitis (HP:0002583) | 3.24603445 |
38 | Optic neuritis (HP:0100653) | 3.22738757 |
39 | Retrobulbar optic neuritis (HP:0100654) | 3.22738757 |
40 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.21762577 |
41 | Recurrent cutaneous fungal infections (HP:0011370) | 3.21762577 |
42 | Autoimmune hemolytic anemia (HP:0001890) | 3.16146813 |
43 | Recurrent sinusitis (HP:0011108) | 3.13598246 |
44 | Orchitis (HP:0100796) | 3.11546910 |
45 | Recurrent abscess formation (HP:0002722) | 3.11292148 |
46 | Vasculitis (HP:0002633) | 3.10697963 |
47 | Abnormality of eosinophils (HP:0001879) | 3.06139258 |
48 | Gastrointestinal stroma tumor (HP:0100723) | 3.02976627 |
49 | Epistaxis (HP:0000421) | 2.98684187 |
50 | Autoimmune thrombocytopenia (HP:0001973) | 2.97646264 |
51 | Chronic diarrhea (HP:0002028) | 2.93509195 |
52 | Gingivitis (HP:0000230) | 2.90226255 |
53 | Encephalitis (HP:0002383) | 2.89574788 |
54 | Hypoproteinemia (HP:0003075) | 2.89206713 |
55 | Bronchitis (HP:0012387) | 2.82947760 |
56 | Urticaria (HP:0001025) | 2.82665974 |
57 | Lymphoma (HP:0002665) | 2.82138741 |
58 | Abnormality of the fingertips (HP:0001211) | 2.81222939 |
59 | IgA deficiency (HP:0002720) | 2.74107169 |
60 | Chronic sinusitis (HP:0011109) | 2.73737518 |
61 | Hemoptysis (HP:0002105) | 2.72026524 |
62 | Aplastic anemia (HP:0001915) | 2.71951060 |
63 | Leukocytosis (HP:0001974) | 2.71599564 |
64 | Joint swelling (HP:0001386) | 2.70516988 |
65 | Eczematoid dermatitis (HP:0000976) | 2.70082997 |
66 | Increased IgM level (HP:0003496) | 2.68331207 |
67 | Petechiae (HP:0000967) | 2.64877651 |
68 | Granulocytopenia (HP:0001913) | 2.61175956 |
69 | Eosinophilia (HP:0001880) | 2.59437967 |
70 | Pustule (HP:0200039) | 2.58951206 |
71 | Arterial thrombosis (HP:0004420) | 2.58527192 |
72 | Hypoplasia of the thymus (HP:0000778) | 2.55137004 |
73 | Cellulitis (HP:0100658) | 2.53760910 |
74 | Microcytic anemia (HP:0001935) | 2.50444013 |
75 | Hypochromic anemia (HP:0001931) | 2.48654393 |
76 | Reticulocytopenia (HP:0001896) | 2.45301103 |
77 | Amaurosis fugax (HP:0100576) | 2.44148162 |
78 | Pulmonary infiltrates (HP:0002113) | 2.43753773 |
79 | Anorexia (HP:0002039) | 2.43238538 |
80 | Poikiloderma (HP:0001029) | 2.43004657 |
81 | Recurrent skin infections (HP:0001581) | 2.40860134 |
82 | Osteomyelitis (HP:0002754) | 2.39098415 |
83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.37911630 |
84 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.34260338 |
85 | Keratoconjunctivitis sicca (HP:0001097) | 2.33154849 |
86 | Entropion (HP:0000621) | 2.27414640 |
87 | Abnormality of the pleura (HP:0002103) | 2.27087018 |
88 | Gangrene (HP:0100758) | 2.27040577 |
89 | Type 2 muscle fiber atrophy (HP:0003554) | 2.26537706 |
90 | Muscle fiber atrophy (HP:0100295) | 2.23830339 |
91 | Hypochromic microcytic anemia (HP:0004840) | 2.23413812 |
92 | Chest pain (HP:0100749) | 2.22905578 |
93 | Increased IgE level (HP:0003212) | 2.22469261 |
94 | Emphysema (HP:0002097) | 2.22115858 |
95 | Mediastinal lymphadenopathy (HP:0100721) | 2.21531866 |
96 | Pulmonary embolism (HP:0002204) | 2.21517431 |
97 | Hypergammaglobulinemia (HP:0010702) | 2.21047511 |
98 | Recurrent bacterial skin infections (HP:0005406) | 2.19790335 |
99 | Basal cell carcinoma (HP:0002671) | 2.19349970 |
100 | Purpura (HP:0000979) | 2.18103778 |
101 | Abnormal number of erythroid precursors (HP:0012131) | 2.17784856 |
102 | Sepsis (HP:0100806) | 2.16379238 |
103 | Abnormality of the prostate (HP:0008775) | 2.14090129 |
104 | Impaired platelet aggregation (HP:0003540) | 2.13448035 |
105 | Abnormal platelet function (HP:0011869) | 2.13448035 |
106 | Abnormality of DNA repair (HP:0003254) | 2.11044165 |
107 | Keratoconjunctivitis (HP:0001096) | 2.10876757 |
108 | Glomerulopathy (HP:0100820) | 2.10746853 |
109 | Premature loss of primary teeth (HP:0006323) | 2.09136855 |
110 | Episodic fever (HP:0001954) | 2.09125727 |
111 | Acute myeloid leukemia (HP:0004808) | 2.07327399 |
112 | Interstitial pulmonary disease (HP:0006530) | 2.06993436 |
113 | Hematochezia (HP:0002573) | 2.04486841 |
114 | Papilledema (HP:0001085) | 2.03309025 |
115 | Verrucae (HP:0200043) | 2.03203747 |
116 | Papilloma (HP:0012740) | 2.03203747 |
117 | Vertigo (HP:0002321) | 2.02457397 |
118 | Recurrent otitis media (HP:0000403) | 1.99811593 |
119 | Abnormality of the endocardium (HP:0004306) | 1.99679334 |
120 | Fatigue (HP:0012378) | 1.98912238 |
121 | Gingival bleeding (HP:0000225) | 1.96922507 |
122 | Hemiplegia (HP:0002301) | 1.96850127 |
123 | Keratitis (HP:0000491) | 1.96065699 |
124 | Skin ulcer (HP:0200042) | 1.94794657 |
125 | Viral hepatitis (HP:0006562) | 1.92067583 |
126 | Acute hepatic failure (HP:0006554) | 1.88121576 |
127 | Stomach cancer (HP:0012126) | 1.86355444 |
128 | Abnormality of the peritoneum (HP:0002585) | 1.86273278 |
129 | Arthralgia (HP:0002829) | 1.85716021 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.21402698 |
2 | TXK | 4.50906549 |
3 | RIPK4 | 3.54836171 |
4 | IKBKE | 2.97978274 |
5 | KDR | 2.75268081 |
6 | JAK3 | 2.71624633 |
7 | KIT | 2.52528616 |
8 | ZAP70 | 2.51021707 |
9 | NLK | 2.46534033 |
10 | PRPF4B | 2.46255937 |
11 | TIE1 | 2.45574486 |
12 | TEC | 2.44864061 |
13 | TGFBR2 | 2.43898851 |
14 | ITK | 2.41273017 |
15 | FGFR4 | 2.34213770 |
16 | TYK2 | 2.25698774 |
17 | TBK1 | 2.25440706 |
18 | TGFBR1 | 2.24521622 |
19 | MAP3K14 | 2.16947860 |
20 | BTK | 2.06452280 |
21 | LCK | 1.72384443 |
22 | FLT3 | 1.70275256 |
23 | STK10 | 1.68232991 |
24 | JAK1 | 1.66507567 |
25 | SYK | 1.56481364 |
26 | FGFR3 | 1.48825978 |
27 | IKBKB | 1.46707930 |
28 | FGR | 1.45875183 |
29 | TNIK | 1.45867847 |
30 | GRK6 | 1.43992257 |
31 | NME2 | 1.40332528 |
32 | CSF1R | 1.38697241 |
33 | MAP2K3 | 1.34941130 |
34 | MAP3K13 | 1.27201943 |
35 | HCK | 1.23448586 |
36 | BLK | 1.22955188 |
37 | MAP3K10 | 1.21178392 |
38 | CSK | 1.13735449 |
39 | MST4 | 1.09732790 |
40 | LRRK2 | 1.08182125 |
41 | MAP3K12 | 1.06950453 |
42 | TESK2 | 1.05417439 |
43 | EEF2K | 1.02813784 |
44 | LYN | 1.02574112 |
45 | MAP2K6 | 1.01095347 |
46 | CAMKK2 | 1.00131343 |
47 | MAP3K11 | 0.99488515 |
48 | FES | 0.98633360 |
49 | PIM1 | 0.96830456 |
50 | MAP3K3 | 0.95943924 |
51 | IRAK4 | 0.94992389 |
52 | BMPR2 | 0.92748469 |
53 | CLK1 | 0.91278554 |
54 | SIK2 | 0.88029190 |
55 | CHUK | 0.86810098 |
56 | ACVR1B | 0.86618596 |
57 | SIK3 | 0.84926297 |
58 | MUSK | 0.84661238 |
59 | CAMKK1 | 0.83805484 |
60 | PRKCH | 0.83123141 |
61 | MARK3 | 0.80652326 |
62 | MAP3K1 | 0.76801929 |
63 | MAP2K2 | 0.76572161 |
64 | RPS6KA4 | 0.75749102 |
65 | PRKCQ | 0.72330623 |
66 | PKN2 | 0.71543089 |
67 | TAOK1 | 0.71301441 |
68 | TNK2 | 0.68302790 |
69 | STK16 | 0.67619353 |
70 | FYN | 0.66932152 |
71 | EPHA3 | 0.66655700 |
72 | YES1 | 0.66124704 |
73 | ADRBK2 | 0.65256484 |
74 | MAPK12 | 0.63694305 |
75 | TRIB3 | 0.63379751 |
76 | CDC42BPA | 0.62925640 |
77 | PRKG2 | 0.61727812 |
78 | MAP3K7 | 0.61573695 |
79 | JAK2 | 0.60248807 |
80 | EPHB1 | 0.58531731 |
81 | HIPK2 | 0.58290358 |
82 | MAPKAPK3 | 0.56284553 |
83 | SMG1 | 0.55296184 |
84 | MYLK | 0.53599391 |
85 | ERN1 | 0.52842578 |
86 | MAPK7 | 0.52704326 |
87 | PTK2B | 0.52107952 |
88 | PASK | 0.52013325 |
89 | IRAK3 | 0.51887425 |
90 | KSR2 | 0.51003913 |
91 | PDPK1 | 0.50735583 |
92 | RPS6KA5 | 0.49797871 |
93 | PRKD2 | 0.49282515 |
94 | GRK7 | 0.46493853 |
95 | TLK1 | 0.46127234 |
96 | PIK3CG | 0.44790937 |
97 | CDK9 | 0.44400563 |
98 | MAPK4 | 0.44048154 |
99 | MATK | 0.43871058 |
100 | GRK1 | 0.43805429 |
101 | RPS6KB2 | 0.43220124 |
102 | MAP3K6 | 0.42682981 |
103 | CDK6 | 0.40093079 |
104 | IGF1R | 0.38531659 |
105 | MARK2 | 0.38310521 |
106 | RET | 0.38181122 |
107 | PIM2 | 0.36890063 |
108 | STK11 | 0.35899135 |
109 | TTN | 0.35779065 |
110 | NUAK1 | 0.35144794 |
111 | MAPKAPK2 | 0.34715614 |
112 | MAPK11 | 0.34132693 |
113 | TAOK2 | 0.32567913 |
114 | TRPM7 | 0.32230696 |
115 | PDK1 | 0.32090031 |
116 | RPS6KC1 | 0.30790252 |
117 | RPS6KL1 | 0.30790252 |
118 | MAPK3 | 0.30158566 |
119 | SGK3 | 0.29911493 |
120 | STK38 | 0.29623244 |
121 | RIPK1 | 0.28867285 |
122 | CAMK1 | 0.27723132 |
123 | NEK9 | 0.27465421 |
124 | STK4 | 0.27121820 |
125 | RPS6KA6 | 0.25856422 |
126 | ABL1 | 0.25557859 |
127 | PRKD1 | 0.24880080 |
128 | INSR | 0.24614974 |
129 | DYRK1B | 0.22381741 |
130 | CDK4 | 0.22330531 |
131 | VRK1 | 0.22189120 |
132 | PTK6 | 0.21921953 |
133 | MKNK1 | 0.21402219 |
134 | IRAK1 | 0.21175131 |
135 | TAOK3 | 0.20910953 |
136 | BRD4 | 0.20412785 |
137 | CDK19 | 0.20268152 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.46410436 |
2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.84621027 |
3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.77802636 |
4 | Ribosome_Homo sapiens_hsa03010 | 2.74334864 |
5 | Measles_Homo sapiens_hsa05162 | 2.70831656 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.69456406 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.66892359 |
8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.54835512 |
9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.53301695 |
10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.45730407 |
11 | Allograft rejection_Homo sapiens_hsa05330 | 2.38172045 |
12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.35557940 |
13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.19052094 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.16905138 |
15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02168127 |
16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.96490939 |
17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.90043715 |
18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.89890554 |
19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.83684312 |
20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57098190 |
21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51776230 |
22 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.40815157 |
23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.38899966 |
24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.33404966 |
25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.31308410 |
26 | Platelet activation_Homo sapiens_hsa04611 | 1.31027497 |
27 | Malaria_Homo sapiens_hsa05144 | 1.30036270 |
28 | Shigellosis_Homo sapiens_hsa05131 | 1.29282959 |
29 | Hepatitis B_Homo sapiens_hsa05161 | 1.28978881 |
30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27836265 |
31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.26175262 |
32 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.25697405 |
33 | Influenza A_Homo sapiens_hsa05164 | 1.24446691 |
34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17257617 |
35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15951224 |
36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.13708350 |
37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12028137 |
38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10335527 |
39 | Base excision repair_Homo sapiens_hsa03410 | 1.09406378 |
40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07382485 |
41 | DNA replication_Homo sapiens_hsa03030 | 1.00860221 |
42 | Apoptosis_Homo sapiens_hsa04210 | 0.96118901 |
43 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96096537 |
44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95741622 |
45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91429995 |
46 | Hepatitis C_Homo sapiens_hsa05160 | 0.90700022 |
47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90247784 |
48 | Spliceosome_Homo sapiens_hsa03040 | 0.88831541 |
49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87515369 |
50 | Phagosome_Homo sapiens_hsa04145 | 0.87301758 |
51 | Legionellosis_Homo sapiens_hsa05134 | 0.87110830 |
52 | RNA degradation_Homo sapiens_hsa03018 | 0.84027521 |
53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83421267 |
54 | Asthma_Homo sapiens_hsa05310 | 0.81296409 |
55 | Mismatch repair_Homo sapiens_hsa03430 | 0.79854402 |
56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78618257 |
57 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73992459 |
58 | Pertussis_Homo sapiens_hsa05133 | 0.73355595 |
59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70705365 |
60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69988768 |
61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69377499 |
62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69352876 |
63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69317615 |
64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67614254 |
65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67504897 |
66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67428542 |
67 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.66167815 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65362465 |
69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64832667 |
70 | Salmonella infection_Homo sapiens_hsa05132 | 0.63944929 |
71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62244814 |
72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61970308 |
73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.61220635 |
74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60138587 |
75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59823379 |
76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58602563 |
77 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58127022 |
78 | Insulin resistance_Homo sapiens_hsa04931 | 0.57733117 |
79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.57611486 |
80 | Homologous recombination_Homo sapiens_hsa03440 | 0.57400824 |
81 | RNA polymerase_Homo sapiens_hsa03020 | 0.57393365 |
82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56522190 |
83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55655083 |
84 | Tuberculosis_Homo sapiens_hsa05152 | 0.55286808 |
85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55069400 |
86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54933780 |
87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52908591 |
88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52156983 |
89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51854757 |
90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50808378 |
91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50730532 |
92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50677732 |
93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50500479 |
94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50112002 |
95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49313475 |
96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49151062 |
97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47366428 |
98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47013845 |
99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46630376 |
100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46364348 |
101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45745878 |
102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44824344 |
103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41875730 |
104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40568689 |
105 | Lysosome_Homo sapiens_hsa04142 | 0.40041241 |
106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39009747 |
107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37696013 |
108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37355441 |
109 | Long-term potentiation_Homo sapiens_hsa04720 | 0.35067227 |
110 | Prostate cancer_Homo sapiens_hsa05215 | 0.34697369 |
111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.33634340 |
112 | ABC transporters_Homo sapiens_hsa02010 | 0.33583117 |
113 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.33200027 |
114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32595635 |
115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32449722 |
116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29962570 |
117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29601197 |
118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29542677 |
119 | Amoebiasis_Homo sapiens_hsa05146 | 0.28599136 |
120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28343301 |
121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27910825 |
122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27216054 |
123 | Purine metabolism_Homo sapiens_hsa00230 | 0.25892816 |
124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.21024164 |
125 | Endocytosis_Homo sapiens_hsa04144 | 0.20934364 |
126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20893011 |
127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20820500 |
128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.19178398 |